NEWS & EVENTS
Rendered image of a translucent human body with the nerves highlighted.

National Commission on Lymphatic Diseases – September 2024 meeting

Virtual
9:10 a.m. - 2:20 p.m. ET.

Description

The quarterly meeting of the National Commission on Lymphatic Diseases (NCLD) will be a hybrid gathering of NCLD members. The meeting will bring together a multidisciplinary panel of stakeholders from multiple agencies and organizations whose mission is to enhance the lives of Americans. The NCLD discussions aim to gather input from the panelists on advancing lymphatic research and lymphatic disease (LD) care to improve the lives of people living with LDs. In addition, the NCLD will explore various institutional models to address the needs of the entire lymphatic community.

The meeting is open to the public via the NIH VideoCast and a recording will be available in that platform.

Panel A Discussion

  • Cecilia Dupecher, Ph.D. - Program Manager, Peer Reviewed Medical Research Program, Congressionally Directed Medical Research Programs, U.S. Army Medical Research and Development Command, Department of Defense (DoD)
  • Amy Jenkins, Ph.D. - Director, Health Science Futures Office, Advanced Research Projects Agency for Health (ARPA-H) and  Kimberley E. Steele, M.D., Ph.D., Program Manager; Health Science Futures Office, ARPA-H
  • Michelle Washko, Ph.D. - Director, National Center for Health Workforce Analysis, Health Resources and Services Administration (HRSA)
  • Lisa Richardson, M.D., M.P.H. - Director of the Division of Cancer Prevention and Control, Centers for Disease Prevention and Control (CDC)
  • Jordan Pomeroy, M.D., Ph.D. - Senior Physician, Division of Cardiology and Nephrology, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), and Sonia Singh, M.D., Clinical Reviewer, Division of Oncology 2, CDER, FDA

Panel B Discussion

  • Laura Lyman Rodriguez, Ph.D. - Deputy Executive Director for Strategy, Planning & Outreach, Patient-Centered Outcomes Research Institute (PCORI)
  • James O'Leary, M.B.A. - Director, Translational Science Inflammation and Immunity, Foundation for NIH (FNIH)
  • Christine Maric-Bilkan, Ph.D. - Program Director, Division of Kidney, Urologic and Hematologic diseases (KUHD), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Susan Mendley, M.D. - Senior Scientific Advisor, KUHD, NIDDK;  Deepak Nihalani, Ph.D. - Program Director, KUHD, NIDDK; Ivonne Schulman, M.D. - Program Director, KUHD, NIDDK, representing NIDDK-supported Kidney Disease Centers.
  • James Kiley, Ph.D. - Director, Division of Lung Diseases, NHLBI, and Neyal Ammary-Risch, M.P.H. - Lead, Health Education & Research Dissemination, Office of Science Policy, Engagement, Education, and Communications (OSPEEC), NHLBI, representing the COPD National Action Plan.

Agenda

NCLD September 30, 2024 Meeting Agenda

Videocast link

https://videocast.nih.gov/watch=55093

Send questions and requests for additional information to: Selen Catania, Ph.D.